Penobscot Investment Management’s Utah Medical Products UTMD Stock Holding History

Penobscot Investment Management’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$276K	Hold	4,000	–	–	0.02%	280
2026 Q1	$248K	Hold	4,000	–	–	0.02%	288
2025 Q4	$224K	Hold	4,000	–	–	0.02%	298
2025 Q3	$252K	Hold	4,000	–	–	0.02%	285
2025 Q2	$228K	Hold	4,000	–	–	0.02%	290
2025 Q1	$224K	Hold	4,000	–	–	0.02%	283
2024 Q4	$246K	Hold	4,000	–	–	0.02%	276
2024 Q3	$268K	Hold	4,000	–	–	0.02%	273
2024 Q2	$267K	Hold	4,000	–	–	0.03%	272
2024 Q1	$284K	Hold	4,000	–	–	0.03%	258
2023 Q4	$337K	Hold	4,000	–	–	0.04%	227
2023 Q3	$344K	Hold	4,000	–	–	0.05%	217
2023 Q2	$373K	Hold	4,000	–	–	0.06%	169
2023 Q1	$379K	Hold	4,000	–	–	0.07%	166
2022 Q4	$402K	Hold	4,000	–	–	0.07%	165
2022 Q3	$341K	Hold	4,000	–	–	0.06%	172
2022 Q2	$344K	Hold	4,000	–	–	0.06%	177
2022 Q1	$359K	Hold	4,000	–	–	0.05%	187
2021 Q4	$400K	Hold	4,000	–	–	0.05%	186
2021 Q3	$371K	Hold	4,000	–	–	0.06%	187
2021 Q2	$340K	Hold	4,000	–	–	0.05%	190
2021 Q1	$346K	Hold	4,000	–	–	0.05%	185
2020 Q4	$337K	Hold	4,000	–	–	0.06%	174
2020 Q3	$319K	Hold	4,000	–	–	0.06%	163
2020 Q2	$354K	Hold	4,000	–	–	0.07%	157
2020 Q1	$376K	Hold	4,000	–	–	0.09%	146
2019 Q4	$432K	Hold	4,000	–	–	0.08%	147
2019 Q3	$383K	Hold	4,000	–	–	0.08%	152
2019 Q2	$383K	Hold	4,000	–	–	0.08%	148
2019 Q1	$353K	Hold	4,000	–	–	0.07%	152
2018 Q4	$332K	Hold	4,000	–	–	0.08%	149
2018 Q3	$377K	Hold	4,000	–	–	0.08%	158
2018 Q2	$441K	Hold	4,000	–	–	0.1%	148
2018 Q1	$395K	Hold	4,000	–	–	0.09%	154
2017 Q4	$326K	Hold	4,000	–	–	0.09%	153
2017 Q3	$294K	Hold	4,000	–	–	0.09%	155
2017 Q2	$290K	Hold	4,000	–	–	0.09%	157
2017 Q1	$249K	Hold	4,000	–	–	0.08%	163
2016 Q4	$291K	Hold	4,000	–	–	0.1%	148
2016 Q3	$239K	Hold	4,000	–	–	0.08%	163
2016 Q2	$252K	Hold	4,000	–	–	0.09%	157
2016 Q1	$250K	Hold	4,000	–	–	0.09%	163
2015 Q4	$234K	Hold	4,000	–	–	0.07%	176
2015 Q3	$215K	Hold	4,000	–	–	0.07%	181
2015 Q2	$239K	Sell	4,000 -1,000	-20%	-$56.3K	0.07%	181
2015 Q1	$299K	Sell	5,000 -1,000	-17%	-$58.8K	0.09%	162
2014 Q4	$360K	Sell	6,000 -1,400	-19%	-$77.5K	0.11%	141
2014 Q3	$361K	Hold	7,400	–	–	0.12%	133
2014 Q2	$381K	Hold	7,400	–	–	0.13%	131
2014 Q1	$428K	Hold	7,400	–	–	0.15%	119
2013 Q4	$423K	Hold	7,400	–	–	0.15%	120
2013 Q3	$440K	Hold	7,400	–	–	0.17%	114
2013 Q2	$402K	Buy	+7,400	New	+$348K	0.17%	116

Other funds holding UTMD

CCMINC

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Penobscot Investment Management's UTMD Position: Q2 2026 in Review

Penobscot Investment Management held its Utah Medical Products (UTMD) position steady in Q2 2026 at 4,000 shares worth $276K. The position accounts for 0.02% of the portfolio, ranked #280.

Penobscot Investment Management first reported a position in UTMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $441K in Q2 2018. 17 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

Penobscot Investment Management held 4,000 shares of Utah Medical Products worth $276K as of Q2 2026.
Penobscot Investment Management left its Utah Medical Products share count unchanged in Q2 2026.
Utah Medical Products made up 0.02% of Penobscot Investment Management's portfolio in Q2 2026, its #280 holding.
Penobscot Investment Management first reported a position in Utah Medical Products in Q2 2013 and has held it in 53 quarters since.
Penobscot Investment Management's Utah Medical Products position peaked at $441K in Q2 2018.
17 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.